# Phase I/II Trial of R-CHOP + Azacytidine in Diffuse Large B Cell Lymphoma

> **NCT01004991** · PHASE1,PHASE2 · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 14 (actual)

## Conditions studied

- Diffuse Large B Cell Lymphoma

## Interventions

- **BIOLOGICAL:** rituximab
- **DRUG:** cyclophosphamide
- **DRUG:** vincristine
- **DRUG:** doxorubicin
- **DRUG:** prednisone
- **DRUG:** azacytidine

## Key facts

- **NCT ID:** NCT01004991
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2013-09
- **Final completion:** 2016-02
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2017-04-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01004991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01004991, "Phase I/II Trial of R-CHOP + Azacytidine in Diffuse Large B Cell Lymphoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01004991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*